Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cariprazine Real-world Use in Bipolar I Disorder: Effectiveness, Functioning, Quality of Life, and Tolerability

NCT06256367 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06256367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06256367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cariprazine Real-world Use in Bipolar I Disorder: Effectiveness, Functioning, Quality of Life, and Tolerability
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
April 18, 2024
Completion date
January 23, 2026
Enrollment
120 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder